537 related articles for article (PubMed ID: 16083197)
21. Relative frequency of the different types of cutaneous T cell and natural killer cell lymphomas in Korea based on the proposed WHO classification and the EORTC classification.
Chang SE; Jee MS; Kim KJ; Choi JH; Sung KJ; Moon KC; Koh JK
J Dermatol; 2003 Jan; 30(1):42-7. PubMed ID: 12598708
[TBL] [Abstract][Full Text] [Related]
22. Extranodal hematopoietic/lymphoid disorders. An introduction.
Burke JS
Am J Clin Pathol; 1999 Jan; 111(1 Suppl 1):S40-5. PubMed ID: 9894468
[TBL] [Abstract][Full Text] [Related]
23. Malignant lymphoma in southern Taiwan according to the revised European-American classification of lymphoid neoplasms.
Chuang SS; Lin CN; Li CY
Cancer; 2000 Oct; 89(7):1586-92. PubMed ID: 11013375
[TBL] [Abstract][Full Text] [Related]
24. Clinicopathological analysis of 598 malignant lymphomas in Taiwan: seven-year experience in a single institution.
Lee MY; Tan TD; Feng AC; Liu MC
Am J Hematol; 2006 Aug; 81(8):568-75. PubMed ID: 16823825
[TBL] [Abstract][Full Text] [Related]
25. [Primary gastric lymphoma].
Barreda B F; Gómez P R; Quispe L D; Sánchez L J; Combe G J; Casanova M L; Celis Z J
Rev Gastroenterol Peru; 2004; 24(3):238-62. PubMed ID: 15483686
[TBL] [Abstract][Full Text] [Related]
26. Extranodal non-hodgkin lymphomas of the oral cavity and maxillofacial region: a clinical study of 58 cases and review of the literature.
Triantafillidou K; Dimitrakopoulos J; Iordanidis F; Gkagkalis A
J Oral Maxillofac Surg; 2012 Dec; 70(12):2776-85. PubMed ID: 22494508
[TBL] [Abstract][Full Text] [Related]
27. Clinicopathological analysis of T-cell lymphoma in Taiwan according to WHO classification: high incidence of enteropathy-type intestinal T-cell lymphoma.
Lee MY; Tsou MH; Tan TD; Lu MC
Eur J Haematol; 2005 Sep; 75(3):221-6. PubMed ID: 16104878
[TBL] [Abstract][Full Text] [Related]
28. The clinicopathological analysis of 303 cases with malignant lymphoma classified according to the World Health Organization classification system in a single institute of Taiwan.
Chen WL; Tsai WC; Chao TY; Sheu LF; Chou JM; Kao WY; Chen YC; Ho CL
Ann Hematol; 2010 Jun; 89(6):553-62. PubMed ID: 20012434
[TBL] [Abstract][Full Text] [Related]
29. Non-Hodgkin's lymphomas presenting as cutaneous lesions.
Yaqoob N; Noorali S; Nasir MI; Pervez S
J Coll Physicians Surg Pak; 2003 Jan; 13(1):29-32. PubMed ID: 12685972
[TBL] [Abstract][Full Text] [Related]
30. Extranodal nasal type NK/T-cell lymphoma: elucidating clinical prognostic factors for risk-based stratification of therapy.
Lee J; Park YH; Kim WS; Lee SS; Ryoo BY; Yang SH; Park KW; Kang JH; Park JO; Lee SH; Kim K; Jung CW; Park YS; Im YH; Kang WK; Lee MH; Ko YH; Ahn YC; Park K
Eur J Cancer; 2005 Jul; 41(10):1402-8. PubMed ID: 15963893
[TBL] [Abstract][Full Text] [Related]
31. Report of an International Network of Cancer Treatment and Research workshop on non-Hodgkin's lymphoma in developing countries.
Naresh KN; Advani S; Adde M; Aziz Z; Banavali S; Bhatia K; Belgaumi A; Ezzat A; Khaled H; Mokhtar N; Norton A; Rohatiner A; Sagar TG; Taciyliz N; Temmim L; Venkatesh C; Yan Tang J; Magrath I
Blood Cells Mol Dis; 2004; 33(3):330-7. PubMed ID: 15528153
[TBL] [Abstract][Full Text] [Related]
32. [Lymphoid lesions of the head and neck].
Costes V
Ann Pathol; 2009 Sep; 29(4):323-34. PubMed ID: 19900637
[TBL] [Abstract][Full Text] [Related]
33. Expression of matrix metalloproteinase 9 is a prognostic factor in patients with non-Hodgkin lymphoma.
Sakata K; Satoh M; Someya M; Asanuma H; Nagakura H; Oouchi A; Nakata K; Kogawa K; Koito K; Hareyama M; Himi T
Cancer; 2004 Jan; 100(2):356-65. PubMed ID: 14716772
[TBL] [Abstract][Full Text] [Related]
34. [World Health Organization (WHO) classification of malignant lymphoma--how is the WHO now?].
Nakamura S
Gan To Kagaku Ryoho; 2004 Feb; 31(2):149-57. PubMed ID: 14997743
[TBL] [Abstract][Full Text] [Related]
35. Overexpression of c-Myc in primary central nervous system lymphoma of Thais.
Assanasen T; Shuangshoti S; Nilyai S; Wannakrairot P; Ruangvejvorachai P; Sawatdee R; Sangprakarn S
J Med Assoc Thai; 2006 Sep; 89 Suppl 3():S40-6. PubMed ID: 17718267
[TBL] [Abstract][Full Text] [Related]
36. CXC chemokine receptor 3 and CC chemokine receptor 4 expression in T-cell and NK-cell lymphomas with special reference to clinicopathological significance for peripheral T-cell lymphoma, unspecified.
Ishida T; Inagaki H; Utsunomiya A; Takatsuka Y; Komatsu H; Iida S; Takeuchi G; Eimoto T; Nakamura S; Ueda R
Clin Cancer Res; 2004 Aug; 10(16):5494-500. PubMed ID: 15328188
[TBL] [Abstract][Full Text] [Related]
37. [Clinical and pathological reassessment of 493 cases of non-Hodgkin's lymphomas according to current WHO classification of lymphoid neoplasms].
Xiao C; Su ZL; Wu QL; Gao HY; Fang JC; Xia ZJ; Guan ZZ
Zhonghua Bing Li Xue Za Zhi; 2005 Jan; 34(1):22-7. PubMed ID: 15796877
[TBL] [Abstract][Full Text] [Related]
38. Analyses of dose-response in radiotherapy for patients with mature T/NK-cell lymphomas according to the WHO classification.
Sakata K; Fuwa N; Kodaira T; Aratani K; Ikeda H; Takagi M; Nishio M; Satoh M; Nakamura S; Satoh H; Hareyama M
Radiother Oncol; 2006 May; 79(2):179-84. PubMed ID: 16644044
[TBL] [Abstract][Full Text] [Related]
39. The protean spectrum of non-Hodgkin lymphomas with prominent involvement of subcutaneous fat.
Massone C; Lozzi GP; Egberts F; Fink-Puches R; Cota C; Kerl H; Cerroni L
J Cutan Pathol; 2006 Jun; 33(6):418-25. PubMed ID: 16776717
[TBL] [Abstract][Full Text] [Related]
40. Extranodal peripheral T-cell and NK-cell neoplasms.
Jaffe ES; Krenacs L; Kumar S; Kingma DW; Raffeld M
Am J Clin Pathol; 1999 Jan; 111(1 Suppl 1):S46-55. PubMed ID: 9894469
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
